Navigation Links
Watson Confirms Exalgo™ Patent Challenge
Date:12/14/2010

MORRISTOWN, N.J., Dec. 14, 2010 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.  Watson's Hydromorphone Hydrochloride Extended-release Tablets are a generic version of Mallinckrodt Inc.'s Exalgo™ tablets, which are indicated for once daily administration for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

Mallinckrodt filed suit against Watson on December 10, 2010 in the United States District Court for the District of New Jersey seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,914,131.  Mallinckrodt's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until April 29, 2013, or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the 8 mg, 12 mg, and 16 mg generic versions of Exalgo™ and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established an
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and medical ... a legal conference in Philadelphia on ... issues, Tom Hagy of HB Litigation Conferences has ... visit HB,s website at http://litigationconferences.com/?p=31886 The ... McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first ... the United States in a trial ... stent for blockages in the main artery of the leg. ... and potentially less risk for stent fracture or re-narrowing after ... single-arm, multicenter clinical trial of the BioMimics 3D Stent System ...
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3First Pennsylvania Patient Treated in Landmark Vascular Study 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
... Ingelheim Pharmaceuticals, Inc. will present new phase Ib data ... annual meeting in Chicago (June 3-7) that indicates combining ... the maximum tested dose controlled disease in all (n=22) ... non-small cell lung cancer (NSCLC) who developed acquired resistance ...
... NEW YORK, May 25, 2011 ... research report is available in its ... Devices Market Outlook in Brazil to ... Infusion Systems, Central Venous Catheters and ...
Cached Medicine Technology:Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 2Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 3Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 4Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 5Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 6Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC 7Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 2Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 3Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 4Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 5Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 6Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 7Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 8Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 9Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 10Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 11
(Date:8/27/2015)... ... ... In an article published July 30th by the New York Times, ... a security firm that is tasked with providing supplemental protection. Called the French Quarter ... the city to provide private security when it is needed in a city that ...
(Date:8/27/2015)... ... August 27, 2015 , ... About ... Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds ... to a Georgia State University study. , While most people don’t develop persistent ...
(Date:8/27/2015)... ... August 27, 2015 , ... Healthpointe is proud to welcome Dr. Ted ... Los Angeles. Licensed to practice Chinese Needle Therapy since 1983, Dr. Priebe specializes in ... Dr. Priebe also practices in Healthpointe’s La Mirada clinic and Garden Grove clinic. ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... and leading biopharmaceutical contract development manufacturing company (CDMO), announced today that it has ... for $205.68M in cash. , The addition of Cytovance Biologics to ...
(Date:8/27/2015)... ... ... King Kullen, America’s First Supermarket, is celebrating 85 years of serving the ... recognized by the Smithsonian Institute as America’s First Supermarket, King Kullen changed the grocery ... Kennedy families have created a culture of caring while building their business. Offering ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:King Kullen Honors Their 85 Years of Success this August 2
... vaccines for new flu strains, other health threats ... Researchers have devised a rapid and efficient method ... called monoclonal antibodies, which mark and neutralize foreign ... accelerate the traditionally challenging task of generating human ...
... Healed by Registered Organ and Tissue Donors, ... tissue donors joined organ transplant recipients at the ... the Department of Motor,Vehicles (DMV) and the three ... lives by signing up on the state-authorized Donate ...
... healthy,eating and neonatal jaundice are among the many topics ... the upcoming Pediatric,Academic Societies Meeting in Honolulu May 2-6. ... more information or to reach one of,the researchers, call ... **ALL RESEARCH IS EMBARGOED UNTIL THE DATE AND TIME ...
... JOLLA, CA Diabetic individuals have a significantly ... molecular connection between the two remains unexplained. Now, ... identified the probable molecular basis for the diabetes ... in the current online issue of Neurobiology of ...
... from Allscripts Document Management; Expects ... Clinical & Financial Investment, CHICAGO and FORT ... of clinical software, connectivity and,information solutions that physicians ... Center Medical Group has selected the Allscripts,Electronic Health ...
... Fall Out Boy, Will.i.am, Alyssa Milano, Say Anything,Perez ... Helping Fuel,Game,s Viral Spread, Developed in Partnership ... Personal Stories of Americans Living With and Without,HIV/AIDS, ... Peabody and,Emmy Award-winning college network, and the Kaiser ...
Cached Medicine News:Health News:Researchers Develop Quick Way to Create Human Antibodies 2Health News:Researchers Develop Quick Way to Create Human Antibodies 3Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 2Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 2Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 2Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 3Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 5Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 6
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... 3 system consists of the Model 7432 ... MemoryMod Software Cartridge. , ,Enterra™ Therapy ... nausea and vomiting associated with gastroparesis when ... relief of symptons for diabetic or idiopathic ...
... Intramuscular Lead is a unipolar lead intended for ... has a ski needle design for easier use ... a fixed electrode length of 1 cm. The ... is available in 35 cm length. Two leads ...
Medicine Products: